Cargando…
Criteria for identifying residual tumours after neoadjuvant chemotherapy of breast cancers: a magnetic resonance imaging study
We investigated magnetic resonance imaging (MRI) criteria identifying residual tumours in patients with triple-negative and human epidermal growth factor receptor type 2-positive (HER2+) breast cancer following neoadjuvant chemotherapy. Retrospectively, 290 patients were included who had undergone n...
Autores principales: | Kim, Yunju, Sim, Sung Hoon, Park, Boram, Chae, In Hye, Han, Jai Hong, Jung, So-Youn, Lee, Seeyoun, Kwon, Youngmi, Park, In Hae, Ko, Kyounglan, Lee, Chan Wha, Lee, Keun Seok, Kang, Han-Sung, Lee, Eun Sook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804856/ https://www.ncbi.nlm.nih.gov/pubmed/33436702 http://dx.doi.org/10.1038/s41598-020-79743-8 |
Ejemplares similares
-
Androgen Receptor as a Predictive Marker for Pathologic Complete Response in Hormone Receptor–Positive and HER-2–Negative Breast Cancer with Neoadjuvant Chemotherapy
por: Lee, Eun-Gyeong, et al.
Publicado: (2023) -
Breast Cancer–Related Lymphedema after Neoadjuvant Chemotherapy
por: Kim, Myungsoo, et al.
Publicado: (2015) -
Progranulin and Breast Cancer Mortality: 13-Year Follow-Up of a Cohort Study
por: Koo, Dong-Hoe, et al.
Publicado: (2023) -
Sentinel Lymph Node Biopsy in Breast Cancer Patients With Pathological Complete Response in the Axillary Lymph Node After Neoadjuvant Chemotherapy
por: Kim, Hyunhee, et al.
Publicado: (2021) -
Clinical Effectiveness of Hypofractionated Proton Beam Therapy for Liver Metastasis From Breast Cancer
por: Kim, Tae Hyun, et al.
Publicado: (2021)